<DOC>
	<DOCNO>NCT02607904</DOCNO>
	<brief_summary>This trial consist 2 part : double-blinded phase open-label extension phase . The open-label extension phase describe record . All participant receive dose GWP42003-P . However , investigator may subsequently decrease increase participant 's dose optimal dose find .</brief_summary>
	<brief_title>An Open-label Extension Trial Investigate Possible Drug-drug Interactions Between Stiripentol Valproate Cannabidiol Patients With Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Stiripentol</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Note : Participants enroll France Sweden must age 1855 year . Key Participant must document magnetic resonance imaging/computerized tomography brain rule progressive neurologic condition . Key Participant clinically significant unstable medical condition epilepsy . Participant history symptom relate drop blood pressure due postural change ( e.g. , dizziness , lightheadedness , blur vision , palpitation , weakness , syncope ) . Participant history suicidal behavior suicidal ideation type 4 5 CSSRS last month . Participant currently use felbamate take less 12 month prior screen visit blind phase trial . Participant currently use past use recreational medicinal cannabis , synthetic cannabinoidbased medication ( include SativexÂ® ) within 3 month prior trial entry . Participant know suspected history drug abuse addiction . Participant unwilling abstain recreational medicinal cannabis , synthetic cannabinoidbased medication ( include Sativex ) duration trial . Participant know suspected hypersensitivity cannabinoids excipients Investigational Medicinal Product ( IMP ) , e.g. , sesame oil .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cannabidiol</keyword>
	<keyword>GWP42003-P</keyword>
	<keyword>Epidiolex</keyword>
	<keyword>Stiripentol</keyword>
	<keyword>Valproate</keyword>
</DOC>